On Thursday, the US FDA has announced the approval of Ervebo. It is the first vaccine that has gained permission from the FDA to treat Ebola or EVD (Ebola Virus Disease). Merck is the pharmaceutical company behind the development of the Ebola-treating vaccine. As per the FDA, the jab can offer protection against EVD, which takes place due to Zaire ebolavirus in adults. Currently, the US is free from the virus, or the instances of EVD are extremely rare. But the illness may emerge in the case already infected people with the virus enter into the nation. Besides, EVD may trap healthcare providers while curing the EVD-infected people.
Ervebo is a form of immunization which offers protection against the bacteria. Health experts say Zaire ebolavirus is the most common reason for Ebola epidemics. Even more, it is the virus liable for the ongoing long-term outbreak in the DRC (Democratic Republic of Congo). It seems like the latest effort of the FDA follows the decision of the European Commission. Reportedly, the EC has legalized the Ebola-preventing vaccine in November. FDA’s Deputy Commissioner for Policy, Legislation, and International Affairs, Anna Abram, said, for now, the risk of EVD remains low in the US. She added the American government is actively devoted to combating Ebola epidemics in Africa.
As per the executive, the latest effort to approve Ervebo marks crucial importance in their attempts to battle Ebola. The agency intends to work in close collaboration with its partners worldwide, including the U.S. Department of Health and Human Services. Anna noted these efforts reveal the FDA’s steady devotion to attaching their proficiency to assist of safe and beneficial medical products to resolve emergency public health requirements and battle infectious diseases, as a part of their crucial mission for public health.
On the other hand, Alex Azar, Secretary of Health and Human Services, said the new vaccine reveals an achievement of American international health leadership. As of today, the EVD has resulted in the death of more than 2000 people in the DRC. Ebola is a highly infectious viral disease. It is spread when a healthy person comes in direct relation with the blood or bodily fluids of an infected person. Ebola can also pass from tissues of diseased people or wild animals. Apart from this, the Ebola virus can remain on materials and surfaces that the patient has touched.